CLINICAL NUTRITION MARKET SIZE REACHED USD 51 BILLION IN 2019, GROWING AT A CAGR OF 8% DURING THE FORECAST PERIOD

Clinical Nutrition Market Size, Share, & Trends Analysis Report by Route Of Administration (Oral or Enteral and Parenteral), Age Group (Adult and Pediatric), Application (Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Cancer, and Others), End-Users (Hospital, LTC, Homecare, and Individual), Distribution (Institutional Sales, Supermarkets & Hypermarkets, Pharmacy, Specialty Stores, Online Channels, and Others), and Geography (North America, APAC, Europe, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2025

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Customize this Report

Most Exhaustive Report

306 Pages

132 Tables

108 Charts

5 Regions

15 Countries

24 Companies

6 Market Segment

Clinical Nutrition Market Report Scope

Report Attribute Details
Market Size (Revenue) USD 51 BILLION (2019)
CAGR 8% (2020-2025)
Base Year 2019
Forecast Year 2020-2025
Market Segments Route Of Administration (Oral Or Enteral and Parenteral), Age Group (Adult and Pediatric), Application (Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Cancer, and Others), End-Users (Hospital, LTC, Homecare, and Individual), Distribution (Institutional Sales, Supermarkets & Hypermarkets, Pharmacy, Specialty Stores, Online Channels, and Others)
Geographic Analysis North America, APAC, Europe, Latin America, and Middle East & Africa
Countries Covered US, Canada, UK, Germany, France, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Saudi Arabia, and UAE

INDUSTRY ANALYSIS

The global clinical nutrition market reached USD 51 billion in 2019 is expected to grow at a CAGR of 8% during the forecast period. The growing geriatric population, the increasing incidence of malnutrition, and the increasing prevalence of communicable and non-communicable chronic diseases across the globe are a few major factors driving the growth of the market. Malnutrition is a widespread healthcare challenge and the lack awareness, affecting the lives of millions of people around the world. A high incidence of malnutrition among hospitalized patients, especially in APAC, is driving the demand for clinical nutrition, which is considered as the most effective solution for patients to reduce the mortality rate.

The outbreak of novel coronavirus has been a global catastrophe. The symptoms of COVID-19 span a spectrum, ranging from mild, self-limiting flu to pneumonia, acute respiratory distress syndrome, and finally, death. A higher percentage of people have died in Europe than in Asia. A recent meta-analysis from China involving 46,248 patients showed that the most prevalent comorbidities in people infected by COVID-19 were hypertension, followed by diabetes, cardiovascular, and respiratory diseases.

SNIPPETS

  • The APAC region is expected to generate the largest growth in demand, generating approx. $15 billion in additional revenue by 2025.
  • The parenteral segment is expected to achieve incremental revenue of over $10 billion during the forecast period. 
  • The online sales segment is expected to witness the fastest growth during the forecast period, growing at a CAGR of 11%.
  • The metabolic disorder segment is likely to observe incremental revenue of over $4.5 billion by 2025. 

CLINICAL NUTRITION MARKET SEGMENTATION

This research report includes a detailed segmentation by

  • Route of Administration
  • Age Group
  • Applications
  • End-users
  • Distribution
  • Geography

INSIGHTS BY ROUTE OF ADMINISTRATION

The oral and enteral segment dominates a majority share of the market. The growing health awareness among consumers remains one of the key factors driving the growth of the market. This trend is expected to continue during the forecast period. Although clinical nutritional supplements are generally prescribed to individuals that are at high risk of malnutrition, oral supplements are witnessing widespread inclusions in dieticians’ recommendations.

The growing demand for multichambered premixed parenteral nutritional supplements is a major factor contributing to the growth of the parenteral segment. The parenteral nutritional products are more popular in Chinese and Indian market. The parenteral segment is expected to grow at a CAGR of over 9% during the forecast period.  

INSIGHTS BY AGE GROUP 

The increasing number of preterm births and the high prevalence of malnutrition among children are primarily driving infant nutrition market growth. Although the number of childbirths is declining globally, the growing awareness of the importance of pediatric nutrition is expected to increase the demand during the forecast period.

The growing health awareness in the general population and the increasing prevalence of chronic diseases are primarily boosting the growth of the adult segment. The geriatric population accounts for a majority share of the adult clinical nutrition segment. The high prevalence of diseases such as cancer, chronic liver disease, COPD, and diabetes is projected to drive the demand for several oral supplement products that support patients.

INSIGHTS BY APPLICATION

The large prevalence of malnutrition among hospitalized patients is particularly driving the market. This segment contributed about 39% of the clinical nutrition market revenue in 2019. Clinical nutrition is considered the most efficient way to treat malnutrition. The APAC region accounts for the largest market for malnutrition clinical nutrition supplements. The region is expected to grow at the fastest CAGR during the forecast period. China, India, Japan, Australia, and South Korea are some of the key markets for nutritional health supplement products in the region.

Metabolic disorders contribute the second largest application segment for the market. In recent years, it has become highly prevalent across the world, particularly in the US. About 34% of adult Americans are estimated to have metabolic disorders. Thus, clinical nutrition is highly recommended for number of patients suffering from this syndrome.

INSIGHTS BY END-USERS

Hospitals constitute the largest end-user for clinical nutrition products globally. The rising incidence of chronic diseases, along with the growing number of preterm births and surgeries, has led to the growth of demand for clinical nutrition in hospitals.

Long-term care facilities (LTC) include includes ambulatory care facilities. The prevalence of protein-energy malnutrition in nursing homes residents range from 25–85%. Malnourishment in the elderly population can lead to poor clinical outcomes and increase the risk of mortality. Thus, clinical nutrition is generally recommended for patients in LTC facilities, which is driving growth.

Clinical nutrition also plays a significant role in home-based healthcare services. The demand for home care services is likely to boost the market for clinical nutrition during the forecast period. The home care segment is expected to witness an absolute growth of 59% during the forecast period. 

INSIGHTS BY DISTRIBUTION

Supermarkets and hypermarkets have been dominating the distribution landscape, and the channel is expected to continue its momentum during the forecast period. Drug stores and pharmacies are the most preferred outlets after supermarkets & hypermarkets. Countries such as India, China, and Japan are oriented toward supermarkets and traditional retail outlets. The other significant countries, such as Australia, depend keenly on drug stores and pharmacies.

The online channel has gained momentum post the rapid internet penetration and advancement in e-commerce shopping sites. The global clinical nutrition market by online channel is expected to reach revenues of $13 billion by 2025. The onset of the COVID-19 pandemic has surged the demand for nutritional products launches and supplements. However, the distribution system has highly been affected due to lockdown and closure of national borders.

INSIGHTS BY GEOGRAPHY

APAC accounts for the largest market share of the global clinical nutrition market. It is expected to witness the fastest growth during the forecast period. The large prevalence of metabolic disorders such as diabetes is boosting the demand for nutritional supplement products. China has the largest number of people who have diabetes globally, with around 116 million people in 2019. The proportion of cancer deaths in Asia is about 57.3% higher than the cancer incidence rate. Thus, with such a prevalence of chronic diseases, the demand for clinical nutrition products is expected to grow. The rise in the aging population in the country is driving the medical nutrition market India.

North America was the second-largest market accounting for 28% of the revenues in 2019. The US region is the major revenue contributor to the North America market. Due to the impact of COVID-19, the sales of medical nutrition products increased significantly in certain regions like China and the US.

INSIGHTS BY VENDORS

The global clinical nutrition market share is fragmented and is highly competitive, with the presence of a large number of significant vendors in the market. The increasing demand for clinically proven formulas and scientific research is the major differentiating factor in the market than can substantially increase the level of investment required. As medical practitioners and pharmacists can serve as influencers for clinical nutrition products, vendors must establish a profitable relationship with them. Constant online engagement is necessary to increase influence among millennial and internet-oriented consumers as they consider online forums as a tool of suggestion and clarity. Collaborations with third-party vendors are crucial for market penetration. The leading vendors in the market are Danone, Nestle Health Science, Baxter, Braun, and Abbott Laboratories.

The global clinical nutrition market research report includes industry analysis with revenue and forecast insights for the following segments: 

Segmentation by Route of Administration   

  • Oral or Enteral
  • Parenteral 

By Type     

  • Pediatric
  • Adult 

By Application  

  • Malnutrition
  • Metabolic Disorders
  • Gastrointestinal Disorders
  • Cancer
  • Others

By End-user     

  • Hospital
  • LTC
  • Homecare
  • Individual 

By Distribution 

  • Institutional Sales
  • Supermarkets & Hypermarkets
  • Pharmacy
  • Specialty Stores
  • Online Channels
  • Others 

By Geography 

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
  • APAC
    • China
    • Japan
    • South Korea
    • Australia
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • UAE

Frequently Asked Questions

The global clinical nutrition market size was valued at USD 51 billion in 2019 and is expected to grow at a CAGR of 8% during 2020-2025
The following factors are likely to contribute to the growth of the clinical nutrition market during the forecast period: Increasing Use of Whey Protein in Clinical Nutrition, Growing Popularity of Home-based Healthcare, High Incidence of Malnutrition Among Hospitalized Patients, and Enteral Nutrition Driving Market Growth
The increasing number of preterm births and the high prevalence of malnutrition among children are primarily driving baby clinical nutrition market growth. The growing health awareness in the general population and the increasing prevalence of chronic diseases are primarily boosting the growth of the adult segment.
The largest market share is held by the following companies: Danone, Nestle Health Science, Baxter, Braun, and Abbott
The APAC region is expected to generate the largest growth in demand, generating approx. $15 billion in additional revenue by 2025.
Due to the impact of COVID-19, the sales of medical nutrition products increased significantly in certain regions like China and the US.
Read More

Select a license type that suits your business needs

Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Select a license type that suits your business needs

Best Value Tag
Coming Soon
  • Stay tuned with us.

YOU CAN GET A FREE SAMPLE OF THIS REPORT!

Fill out your details & get your free sample

Our Clients

Licence Types What are these?

Our Clients Speak

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date